| GRANT | DATE | AMOUNT | PROGRAM |
|---|---|---|---|
|
Jaeb Center For Health Research Foundation, Inc.
Data management and site coordination for clinical study evaluating an AID system for pregnant individuals with T1D |
05.20.2026 | $1,368,321.00 | Type 1 Diabetes, Improve Outcomes |
|
Foundation for Innovative New Diagnostics FIND
Access to Continuous Glucose Monitoring for Equity in Diabetes Management 2.0 (ACCEDE 2.0): Scaling sustainable access models for affordable, quality-assured CGMs in Africa and Asia through evidence generation, policy engagement, improving market health, and capacity strengthening |
05.06.2026 | $3,171,729.00 | Type 1 Diabetes, Improve Outcomes |
|
Washington University
Modeling T1D glucagon secretion and screening modulatory compounds |
05.06.2026 | $550,000.00 | Type 1 Diabetes, Prevent & Delay |
|
American Diabetes Association, Inc.
ADA Training and Mentorship - The Connected Journey |
03.24.2026 | $3,000,000.00 | Type 1 Diabetes, Improve Outcomes |
|
Vivli, Inc.
Making T1D datasets publicly available |
03.12.2026 | $150,000.00 | Type 1 Diabetes, Improve Outcomes |
|
Université libre de Bruxelles
Advancing toward a first-in-human beta cell imaging trial using a single domain antibody targeting DPP6 |
02.26.2026 | $1,137,649.00 | Type 1 Diabetes, Prevent & Delay |
|
Tidepool Project
Expansion of the Tidepool+ Platform |
01.12.2026 | $3,000,000.00 | Type 1 Diabetes, Improve Outcomes |
|
The Trustees of Columbia University in the City of New York
Role of pancreas-associated myeloid cells in homeostasis and T1D |
01.12.2026 | $900,000.00 | Type 1 Diabetes, Prevent & Delay |
|
T1D Fund: A Breakthrough T1D Venture, LLC
Drive investment in T1D drug development |
01.12.2026 | $3,000,000.00 | Type 1 Diabetes, Prevent & Delay |
|
The University of British Columbia
High-dimensional analysis of innate immune cells in T1D pancreas |
01.12.2026 | $900,000.00 | Type 1 Diabetes, Prevent & Delay |
|
Mass General Brigham for the Massachusetts General Hospital
Leveraging immunosuppressive myeloid function to prevent type I diabetes |
01.12.2026 | $897,746.00 | Type 1 Diabetes, Prevent & Delay |
|
American College of Diabetology Inc
Improve the diabetes training opportunities for PCPs - Phase 2 |
12.16.2025 | $2,395,266.00 | Type 1 Diabetes, Improve Outcomes |
|
Georgetown University
Advancing Access to High Quality, Affordable Diabetes Care Through Private Health Insurance Regulation - Phase 2 |
12.16.2025 | $1,156,353.00 | Type 1 Diabetes, Improve Outcomes |
|
Center for Health Care Strategies, Inc.
CHCS Medicaid Access Accelerator - Phase 2 |
12.03.2025 | $3,129,296.00 | Type 1 Diabetes, Improve Outcomes |
|
The Regents of the University of Colorado, Denver
Natural Protective Mechanisms of HLA-DQ6 (DQB1*06:02) against T1D Development |
11.19.2025 | $1,378,224.00 | Type 1 Diabetes, Prevent & Delay |
|
The City of Hope
Immune regulatory mechanisms in HLA-DQ6 mediated protection from T1D |
11.19.2025 | $877,453.00 | Type 1 Diabetes, Prevent & Delay |
|
Cold Spring Harbor Laboratory
Hypoglycemia in Diabetes Course |
11.05.2025 | $178,200.00 | Type 1 Diabetes, Prevent & Delay |
|
Vanderbilt University
Normalizing glucagon content and secretion in T1D through pharmacological restoration |
11.05.2025 | $825,000.00 | Type 1 Diabetes, Prevent & Delay |
|
University of Utah
Induction of peripheral tolerance to beta cell antigens by specific targeting of human Langerin+ Dendritic Cells |
10.21.2025 | $393,421.00 | Type 1 Diabetes, Prevent & Delay |
|
Shatterproof A Nonprofit Corp
2026-2028 general operating support |
10.21.2025 | $600,000.00 | Type 1 Diabetes, Other |
|
Prev
12...48
Next
1 - 20 of 957 results
|
|||